Posted on: Sat 24-06-2023

The National Agency for Food and Drugs Administration and Control (NAFDAC) has alerted Nigerians of an unregistered substandard drug product known as Original Chest and Lung Tablets circulating in the country.

NAFDAC disclosed this in a statement on its website.

The agency warned the public not to purchase the product as it is not in their database.

“The National Agency for Food and Drugs Administration and Control is notifying the public of an unregistered substandard drug product named Original Chest and Lung Tablets circulating in Nigeria.

“This product was discovered during a post-marketing surveillance activity carried out by officials of the Agency.

Public Alert No. 020/2023.

Alert on unregistered drug product (Original Chest and Lung Tablets) circulating in Nigeria.#NafdacALERTShttps://t.co/yBohP9DMBS pic.twitter.com/H8JqZH54Gr

— NAFDAC NIGERIA (@NafdacAgency) June 23, 2023

“On investigation, it was discovered that numerous versions of the substandard product are in circulation. The product is without batch number, manufacturing date and expiry date.

“Please note that the product is not in the NAFDAC database. However, importers, distributors, retailers, and consumers are advised to exercise caution and vigilance within the supply chain to avoid the importation, distribution, sale, and use of substandard (contaminated) syrups. All medical products must be obtained from authorized/licensed suppliers. The products’ authenticity and physical condition should be carefully checked.

“NAFDAC implores members of the public to desist from purchasing medicinal products from unauthorized sources such as roadside vendors and street hawkers as fake drugs are mostly smuggled into the country from neighbouring countries and distributed through such inappropriate channels.

“Anyone in possession of the above-mentioned product is advised to discontinue sale or use and submit stock to the nearest NAFDAC office.

“If you, or someone you know, have used this product, or suffered any adverse reaction/event after use, you are advised to seek immediate medical advice from a qualified healthcare professional.”

---

---